<VariationArchive VariationID="582788" VariationName="NM_004655.4(AXIN2):c.1822del (p.Leu608fs)" VariationType="Deletion" Accession="VCV000582788" Version="11" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="569578" VariationID="582788">
      <GeneList>
        <Gene Symbol="AXIN2" FullName="axin 2" GeneID="8313" HGNC_ID="HGNC:904" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="65528563" stop="65561648" display_start="65528563" display_stop="65561648" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="63524680" stop="63557739" display_start="63524680" display_stop="63557739" Strand="-" />
          </Location>
          <OMIM>604025</OMIM>
          <Haploinsufficiency last_evaluated="2021-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AXIN2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AXIN2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004655.4(AXIN2):c.1822del (p.Leu608fs)</Name>
      <CanonicalSPDI>NC_000017.11:65536953:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="65536954" stop="65536954" display_start="65536954" display_stop="65536954" variantLength="1" positionVCF="65536953" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="63533072" stop="63533072" display_start="63533072" display_stop="63533072" variantLength="1" positionVCF="63533071" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L608fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_296" sequenceAccession="LRG_296" change="g.29669del">
            <Expression>LRG_296:g.29669del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_296t1" sequenceAccession="LRG_296t1" change="c.1822del">
            <Expression>LRG_296t1:c.1822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.63533072del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.63533072del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.65536954del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.65536954del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012142.1" sequenceAccession="NG_012142" sequenceVersion="1" change="g.29669del">
            <Expression>NG_012142.1:g.29669del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004655.4" sequenceAccession="NM_004655" sequenceVersion="4" change="c.1822del" MANESelect="true">
            <Expression>NM_004655.4:c.1822del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004646.3" sequenceAccession="NP_004646" sequenceVersion="3" change="p.Leu608fs">
            <Expression>NP_004646.3:p.Leu608fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363813.1" sequenceAccession="NM_001363813" sequenceVersion="1" change="c.1712+370del">
            <Expression>NM_001363813.1:c.1712+370del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004655.3" sequenceAccession="NM_004655" sequenceVersion="3" change="c.1822del">
            <Expression>NM_004655.3:c.1822del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1567754914" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004655.4(AXIN2):c.1822del (p.Leu608fs) AND Oligodontia-cancer predisposition syndrome" Accession="RCV000706948" Version="8">
        <ClassifiedConditionList TraitSetID="1632">
          <ClassifiedCondition DB="MedGen" ID="C1837750">Oligodontia-cancer predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-29" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004655.4(AXIN2):c.1822del (p.Leu608fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002406650" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">15042511</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21416598</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32807118</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1632" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5670" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">TOOTH AGENESIS-COLORECTAL CANCER SYNDROME</ElementValue>
                <XRef Type="MIM" ID="608615" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oligodontia-colorectal cancer syndrome</ElementValue>
                <XRef ID="Oligodontia-colorectal+cancer+syndrome/9037" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oligodontia-cancer predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0012075" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ODCRCS</ElementValue>
                <XRef Type="MIM" ID="608615" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522383" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591173" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324342" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528518" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528654" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17376" />
                <XRef ID="17376" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <XRef ID="300576" DB="Orphanet" />
              <XRef ID="C1837750" DB="MedGen" />
              <XRef ID="MONDO:0012075" DB="MONDO" />
              <XRef Type="MIM" ID="608615" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1608033" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="1833672|MedGen:C1837750" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000836023" DateUpdated="2024-02-20" DateCreated="2018-10-10" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32807118</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21416598</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15042511</ID>
          </Citation>
          <Comment>This premature translational stop signal has been observed in individual(s) with neuroblastoma, oligodontia and gastric adenoma (PMID: 32807118). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 582788). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu608Phefs*81) in the AXIN2 gene. Loss-of-function variants in AXIN2 are known to be pathogenic (PMID: 21416598, 15042511). However, tissue-specific alternative splicing of AXIN2 gene results in functional isoform lacking in-frame exon 7 (also known as exon 6, PMID: 15735151). For this reason the clinical significance of loss of function variants in exon 7 is currently uncertain.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AXIN2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.63533072del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837750" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5201528" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a847268|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002710440" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32807118</ID>
          </Citation>
          <Comment>The c.1822delC pathogenic mutation, located in coding exon 6 of the AXIN2 gene, results from a deletion of one nucleotide at nucleotide position 1822, causing a translational frameshift with a predicted alternate stop codon (p.L608Ffs*81). This alteration has been observed in one individual diagnosed with an olfactory neuroblastoma, hypodontia and gastric adenoma (Macklin-Mantia SK et al. BMC Med Genet, 2020 08;21:161). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AXIN2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004655.3:c.1822delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1608033" TraitType="Disease" MappingType="XRef" MappingValue="C1837750" MappingRef="MedGen">
        <MedGen CUI="C1837750" Name="Oligodontia-cancer predisposition syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5201528" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

